心血管康复医学杂志2024,Vol.33Issue(2) :256-259.DOI:10.3969/j.issn.1008-0074.2024.02.30

慢性心力衰竭与肌少症发病机制及治疗的研究进展

Research progress in pathogenesis and treatment of chronic heart failure and sarcopenia

刘婷婷 刘海霞 周萍
心血管康复医学杂志2024,Vol.33Issue(2) :256-259.DOI:10.3969/j.issn.1008-0074.2024.02.30

慢性心力衰竭与肌少症发病机制及治疗的研究进展

Research progress in pathogenesis and treatment of chronic heart failure and sarcopenia

刘婷婷 1刘海霞 2周萍1
扫码查看

作者信息

  • 1. 哈尔滨医科大学附属第二医院老年病科,黑龙江哈尔滨 150081
  • 2. 上海市第四人民医院老年病科
  • 折叠

摘要

肌少症是一种与增龄相关的老年综合征,其特征是肌肉质量、力量和躯体功能的逐渐减退.慢性心力衰竭(Chronic heart failure,CHF)是各种心血管疾病的最终阶段.CHF是心脏衰老的主要发病机制,并可能发展为心脏恶病质.此外,CHF可引起多种代谢并发症,也可能导致肌少症.因此,肌少症可能作为与心衰相关的衰弱、残疾和死亡率的有力预测因子.本文的目的是对心力衰竭与肌少症的发病机制及治疗的最新进展作一综述.

Abstract

Sarcopenia is a geriatric syndrome associated with aging characterized by a gradual decline in muscle mass,strength,and physical function.Chronic heart failure(CHF)is the final stage of various cardiovascular diseases,which is the main pathogenesis of cardiac aging and may develop into cardiac cachexia.In addition,CHF can cause a variety of metabolic complications and may also lead to sarcopenia.Therefore,sarcopenia may be a strong predic-tor of frailty,disability and mortality associated with heart failure.The purpose of this article is to review the re-cent progress in the pathogenesis and treatment of heart failure and sarcopenia.

关键词

心力衰竭/肌减少症/治疗

Key words

Heart failure/Sarcopenia/Therapy

引用本文复制引用

出版年

2024
心血管康复医学杂志
福建省康复医学会 中国康复医学会

心血管康复医学杂志

CSTPCD
影响因子:1.157
ISSN:1008-0074
参考文献量42
段落导航相关论文